174 related articles for article (PubMed ID: 12405163)
1. A primary immunodeficiency disorder associated with absence of lymphoid germinal centers.
Eisenstein EM; Aker M; Savoldi G; Jaffe R; Prus D
J Clin Immunol; 2002 Sep; 22(5):297-305. PubMed ID: 12405163
[TBL] [Abstract][Full Text] [Related]
2. Immunohistologic analysis of ineffective CD40-CD40 ligand interaction in lymphoid tissues from patients with X-linked immunodeficiency with hyper-IgM. Abortive germinal center cell reaction and severe depletion of follicular dendritic cells.
Facchetti F; Appiani C; Salvi L; Levy J; Notarangelo LD
J Immunol; 1995 Jun; 154(12):6624-33. PubMed ID: 7539026
[TBL] [Abstract][Full Text] [Related]
3. CD40 ligand and its role in X-linked hyper-IgM syndrome.
Callard RE; Armitage RJ; Fanslow WC; Spriggs MK
Immunol Today; 1993 Nov; 14(11):559-64. PubMed ID: 7506037
[TBL] [Abstract][Full Text] [Related]
4. The biology of the human ligand for CD40.
Spriggs MK; Fanslow WC; Armitage RJ; Belmont J
J Clin Immunol; 1993 Nov; 13(6):373-80. PubMed ID: 7507124
[No Abstract] [Full Text] [Related]
5. Molecular pathology of X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1).
Ramesh N; Fuleihan R; Geha R
Immunol Rev; 1994 Apr; 138():87-104. PubMed ID: 7520884
[No Abstract] [Full Text] [Related]
6. Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features.
Lougaris V; Badolato R; Ferrari S; Plebani A
Immunol Rev; 2005 Feb; 203():48-66. PubMed ID: 15661021
[TBL] [Abstract][Full Text] [Related]
7. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome.
Aruffo A; Farrington M; Hollenbaugh D; Li X; Milatovich A; Nonoyama S; Bajorath J; Grosmaire LS; Stenkamp R; Neubauer M
Cell; 1993 Jan; 72(2):291-300. PubMed ID: 7678782
[TBL] [Abstract][Full Text] [Related]
8. Hyper IgM syndrome associated with defective CD40-mediated B cell activation.
Conley ME; Larché M; Bonagura VR; Lawton AR; Buckley RH; Fu SM; Coustan-Smith E; Herrod HG; Campana D
J Clin Invest; 1994 Oct; 94(4):1404-9. PubMed ID: 7523449
[TBL] [Abstract][Full Text] [Related]
9. Hyper IgM with combined immunodeficiency.
Goddard EA; Hughes EJ; Beatty DW
J Clin Lab Immunol; 1991 Aug; 35(4):183-8. PubMed ID: 1668855
[TBL] [Abstract][Full Text] [Related]
10. Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome.
Ameratunga R; Lederman HM; Sullivan KE; Ochs HD; Seyama K; French JK; Prestidge R; Marbrook J; Fanslow WC; Winkelstein JA
J Pediatr; 1997 Jul; 131(1 Pt 1):147-50. PubMed ID: 9255207
[TBL] [Abstract][Full Text] [Related]
11. Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM.
Korthäuer U; Graf D; Mages HW; Brière F; Padayachee M; Malcolm S; Ugazio AG; Notarangelo LD; Levinsky RJ; Kroczek RA
Nature; 1993 Feb; 361(6412):539-41. PubMed ID: 7679206
[TBL] [Abstract][Full Text] [Related]
12. CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes.
Bhushan A; Covey LR
Immunol Res; 2001; 24(3):311-24. PubMed ID: 11817328
[TBL] [Abstract][Full Text] [Related]
13. Hyper IgM syndrome: two mutations distinguish HIM.
Foy TM; Masters SR; Noelle RJ
J Clin Invest; 1994 Oct; 94(4):1349-50. PubMed ID: 7523448
[No Abstract] [Full Text] [Related]
14. Molecular basis for human immunodeficiencies.
Hammarström L; Gillner M; Smith CI
Curr Opin Immunol; 1993 Aug; 5(4):579-84. PubMed ID: 7692881
[TBL] [Abstract][Full Text] [Related]
15. Brief report: correction of X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation.
Thomas C; de Saint Basile G; Le Deist F; Theophile D; Benkerrou M; Haddad E; Blanche S; Fischer A
N Engl J Med; 1995 Aug; 333(7):426-9. PubMed ID: 7542361
[No Abstract] [Full Text] [Related]
16. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation.
Kawabe T; Naka T; Yoshida K; Tanaka T; Fujiwara H; Suematsu S; Yoshida N; Kishimoto T; Kikutani H
Immunity; 1994 Jun; 1(3):167-78. PubMed ID: 7534202
[TBL] [Abstract][Full Text] [Related]
17. The molecular basis of lymphoid architecture and B cell responses: implications for immunodeficiency and immunopathology.
Vinuesa CG; Cook MC
Curr Mol Med; 2001 Dec; 1(6):689-725. PubMed ID: 11899257
[TBL] [Abstract][Full Text] [Related]
18. Hyper-IgM immunodeficiency with disseminated cryptococcosis.
Iseki M; Anzo M; Yamashita N; Matsuo N
Acta Paediatr; 1994 Jul; 83(7):780-2. PubMed ID: 7949815
[TBL] [Abstract][Full Text] [Related]
19. Clinical spectrum of X-linked hyper-IgM syndrome.
Levy J; Espanol-Boren T; Thomas C; Fischer A; Tovo P; Bordigoni P; Resnick I; Fasth A; Baer M; Gomez L; Sanders EA; Tabone MD; Plantaz D; Etzioni A; Monafo V; Abinun M; Hammarstrom L; Abrahamsen T; Jones A; Finn A; Klemola T; DeVries E; Sanal O; Peitsch MC; Notarangelo LD
J Pediatr; 1997 Jul; 131(1 Pt 1):47-54. PubMed ID: 9255191
[TBL] [Abstract][Full Text] [Related]
20. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome.
Allen RC; Armitage RJ; Conley ME; Rosenblatt H; Jenkins NA; Copeland NG; Bedell MA; Edelhoff S; Disteche CM; Simoneaux DK
Science; 1993 Feb; 259(5097):990-3. PubMed ID: 7679801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
